Clinical Study to Investigate the Efficacy and Safety of NT 201 Compared to Placebo in the Treatment of Chronic Troublesome Drooling Associated With Neurological Disorders and/or Intellectual Disability
Clinical trial NCT02270736 · COMPLETED
Trial details
- NCT number
- NCT02270736
- Sponsor
- Merz Pharmaceuticals GmbH
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-02-09
- Primary completion
- 2018-02-23
- Enrollment
- 256
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.